MARKET

OMCL

OMCL

Omnicell
NASDAQ

Real-time Quotes | Nasdaq Last Sale

139.03
-1.40
-1.00%
After Hours: 139.03 0 0.00% 16:19 06/11 EDT
OPEN
140.62
PREV CLOSE
140.43
HIGH
141.70
LOW
137.62
VOLUME
230.14K
TURNOVER
--
52 WEEK HIGH
146.99
52 WEEK LOW
62.24
MARKET CAP
6.00B
P/E (TTM)
178.82
1D
5D
1M
3M
1Y
5Y
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021
 
Benzinga · 3d ago
JP Morgan Initiates Coverage On Omnicell with Neutral Rating, Announces Price Target of $146
JP Morgan analyst Anne Samuel initiates coverage on Omnicell (NASDAQ:OMCL) with a Neutral rating and announces Price Target of $146.
Benzinga · 3d ago
JPMorgan Starts Omnicell at Neutral With $146 Price Target
MT Newswires · 4d ago
Omnicell Stock Gives Every Indication Of Being Significantly Overvalued
GuruFocus News · 4d ago
CPSI vs. OMCL: Which Stock Is the Better Value Option?
Zacks.com · 06/03 15:40
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
Zacks.com · 05/26 10:20
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021
 
Benzinga · 05/24 14:02
MorphoSys upgraded at Morgan Stanley, Aveanna wins positive views; and more in today’s analyst action
MorphoSys upgraded at Morgan Stanley citing the potential of MonjuviMorphoSys (MOR) has lost ~23.8% in the year so far. Noting that the pullback has brought the shares towards its bear
Seekingalpha · 05/24 13:02
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OMCL. Analyze the recent business situations of Omnicell through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OMCL stock price target is 152.67 with a high estimate of 170.00 and a low estimate of 110.00.
EPS
Institutional Holdings
Institutions: 504
Institutional Holdings: 48.15M
% Owned: 111.48%
Shares Outstanding: 43.19M
TypeInstitutionsShares
Increased
100
1.77M
New
69
2.19M
Decreased
142
2.36M
Sold Out
41
795.23K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.27%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Chairman/Director/President/Chief Executive Officer
Randall Lipps
Chief Financial Officer/Executive Vice President
Peter Kuipers
Chief Human Resource Officer/Executive Vice President
Christine Mellon
Executive Vice President/Chief Administrative Officer
Daniel Johnston
Executive Vice President
Scott Seidelmann
Lead Director/Independent Director
James Judson
Director
Robin Seim
Independent Director
Joanne Bauer
Independent Director
Vance Moore
Independent Director
Mark Parrish
Independent Director
Bruce Scott
Independent Director
Bruce Smith
Independent Director
Sara White
No Data
About OMCL
Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Webull offers kinds of Omnicell, Inc. stock information, including NASDAQ:OMCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMCL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OMCL stock methods without spending real money on the virtual paper trading platform.